Holen Sie sich die Stockscreener-App
77.93
1.18%
0.91
Handel nachbörslich:
77.71
-0.22
-0.28%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
Big Health Raises $23.7M from .406 Ventures, AlleyCorp, CVS Ventures, Blue Venture Fund - Behavioral Health Business
Analysts See Multiple Growth Levers For CVS In 2026 - Benzinga
Analysts See Multiple Growth Levers For CVS Health In 2026 - Benzinga
Is CVS’s Reaffirmed 2026 EPS Guidance Amid Medicare Advantage Uncertainty Altering The Investment Case For CVS Health (CVS)? - Yahoo Finance
Humana’s profit outlook adds to health insurance gloom - Modern Healthcare News
CVS Q4 Deep Dive: Pharmacy Turnaround and Regulatory Shifts Shape Outlook - Finviz
Mark Cuban Urges Trump To 'Put His Weight Behind' Josh Hawley, Elizabeth Warren's 'Break Up Big Medicine Act' - Benzinga
Decoding CVS Health Corp (CVS): A Strategic SWOT Insight - GuruFocus
CVS defends its scale as CEO Joyner aligns with Trump, blames pharma for high costs - The Business Journals
CVS Health Earnings Call: Cash, Growth And Cost Risks - TipRanks
CVS annual profit guidance misses Wall Street estimates - The Boston Globe
CVS Health Corp (CVS) Q4 2025 Earnings Call Highlights: Strong R - GuruFocus
CVS Reiterates 2026 Profit Outlook, Shares Slide 3.7% Despite Q4 Beat - TradingView
CVS year-end profit falls to $1.7B in 2025 - Providence Business News
What's Going On With CVS Health Stock Tuesday?CVS Health (NYSE:CVS) - Benzinga
House subpoenas CVS, Kaiser Permanente, others in ACA fraud probe - Modern Healthcare News
Gold Moves Lower; CVS Health Earnings Top Views - Benzinga
CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline - AlphaStreet News
CVS Health (CVS) Surpasses Expectations with Strong 2025 Performance - GuruFocus
CVS Health grapples with high costs, strategic reset - Modern Healthcare News
CVS Health Reports Strong Q4 2025 Earnings with Positive Outlook - Intellectia AI
CVS Earnings: 2026 Guidance Maintained After Strong Trends In Late 2025 - Morningstar
CVS Anticipates Medicare Margin Growth by 2026 - GuruFocus
CVS Faces Challenges with Proposed Rates Amid Rising Costs - GuruFocus
Jim Cramer on CVS: "I Think It's a Fascinating Time to Own the Stock" - Finviz
Jim Cramer on CVS: “I Think It’s a Fascinating Time to Own the Stock” - Insider Monkey
CVS Health Q4 2025 slides: Revenue jumps 8.2%, stock falls despite earnings beat - Investing.com
CVS Health posts strong Q4 revenue, raises full-year guidance - Proactive financial news
Earnings call transcript: CVS Health Q4 2025 beats forecasts, stock dips By Investing.com - Investing.com India
CVS Keeps 2026 Forecast Steady Amid Tumult in Health Insurance - Bloomberg.com
Earnings call transcript: CVS Health Q4 2025 beats forecasts, stock dips - Investing.com
CVS Health (CVS) Subpoenaed in ACA Fraud Investigation - GuruFocus
AI for investors - MLQ.ai
CVS Beats Q4 Revenue Estimates, Highlights Strategic Growth - GuruFocus
CVS Forecasts FY26 Operating Income in Billions - GuruFocus
CVS Maintains FY26 Effective Tax Rate Projection at 25.3% - GuruFocus
Republican-led House panel issues subpoenas to eight health insurers: Axios - CNBC
CVS Health Reports Q4 Beat but Maintains Full-Year Outlook - Intellectia AI
CVS Health (NYSE:CVS) Surprises With Q4 CY2025 Sales - Finviz
CVS Health Corp (NYSE:CVS) Beats Q4 Estimates but Shares Dip on Cautious Outlook - ChartMill
CVS Lowers Fiscal Year 2026 Cash Flow Outlook - GuruFocus
CVS Health (CVS) Surpasses Q4 Expectations with Strong Revenue G - GuruFocus
CVS Health beats Q4 expectations, cash flow guidance lowered - Investing.com
CVS Health Insiders Placed Bullish Bets Worth US$2.10m - Yahoo Finance
CVS Health beats quarterly profit expectations on pharmacy performance By Reuters - Investing.com
CVS HEALTH Corp SEC 10-K Report - TradingView
CVS Health Corp earnings beat by $0.09, revenue topped estimates - Investing.com
CVS Health keeps in place 2026 forecast, eyes topping it - Reuters
CVS Health beats quarterly profit expectations on pharmacy performance - Yahoo Finance
CVS posts Q4 sales of $105.7B, up 8.2% - breakingthenews.net
US House panel issues subpoenas to eight health insurers on alleged Obamacare fraud - Reuters
Coca-Cola, CVS Health And 3 Stocks To Watch Heading Into TuesdayCoca-Cola (NYSE:KO) - Benzinga
Here's what to expect at CVS's upcoming earnings call - The Business Journals
CVS (CVS) Q4 Profit Expected to Drop 16% Amid Revenue Growth - GuruFocus
CVS Stock Quote Price and Forecast - CNN
Aetna Medicaid and NACHC team up to improve outcomes in hypertension management - CVS Health
A Peek at CVS Health's Future Earnings - Benzinga
Tech Rally: Is CVS Health Corporation stock overvalued or fairly priced2025 Key Lessons & Intraday High Probability Alerts - baoquankhu1.vn
CVS Health Corporation (CVS) Under Pressure From Medicare Proposal, Argus Holds Positive View - Insider Monkey
CVS Health (CVS) Q4 Earnings: What To Expect - Finviz
CVS Health Stock at a Crossroads: Value Trap or Quiet Turnaround Story? - AD HOC NEWS
CVS (CVS) Accepts TrumpRx Discount Cards for Prescription Drugs - GuruFocus
CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists - Reuters
CVS Health (CVS) Embraces TrumpRx Discount Cards for Medication Savings - GuruFocus
CVS Pharmacy now accepting TrumpRx discount cards - Investing.com
2.42%
1.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):